Form 4: Amprius CEO Sells 1 Million Shares After Option Exercises

Sentiment:

Insider Transaction Report


Amprius Technologies CEO Kang Sun exercised stock options and subsequently sold 1 million shares of common stock for over $10 million under a pre-arranged trading plan.

Summary

  • Kang Sun, CEO and Director of Amprius Technologies, Inc. (AMPX), engaged in a series of transactions on November 17, 2025.
  • These transactions included the exercise of stock options to acquire a total of 1,000,000 shares of common stock at exercise prices ranging from $0.05 to $0.98 per share.
  • Immediately following the option exercises, Mr. Sun sold 1,000,000 shares of Amprius common stock at an average price of $10.5953 per share, with individual sales ranging from $10.19 to $11.30.
  • All reported exercises and sales were conducted pursuant to a Rule 10b5-1 trading plan adopted by Mr. Sun on August 18, 2025.
  • Following these transactions, Mr. Sun directly beneficially owns 1,472,306 shares of common stock, which includes 1,411,769 restricted stock units.
  • Additionally, 274,275 shares are indirectly beneficially owned through the KANG & CECILLIA SUN FAMILY REVOCABLE TRUST.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While a large insider sale can sometimes be viewed negatively, the execution under a pre-arranged Rule 10b5-1 trading plan mitigates concerns about opportunistic selling. It represents a planned monetization of vested equity by the CEO.

Positives

  • The CEO successfully monetized a significant portion of vested stock options, realizing over $10.5 million from the sale of 1 million shares.
  • The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, indicating a planned and non-opportunistic sale.

Negatives

  • A large insider sale, even if pre-planned, can sometimes be perceived negatively by the market, potentially signaling a lack of confidence, although the 10b5-1 plan mitigates this concern.

Future Outlook

NA

Industry Context

This Form 4 filing details routine insider transactions by a key executive, which is a common occurrence in publicly traded companies. It reflects a planned monetization event for vested equity rather than a direct commentary on broader industry trends or competitive landscape.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Authorization of FilersKang Sun granted a Power of Attorney to Thomas M Stepien, Ricardo C. Rodriguez, and Siyu Jiang to prepare and file SEC forms (Forms 3, 4, 5, 13D, 13G, 144) on his behalf as an officer, director, or stockholder of Amprius Technologies, Inc.2025-11-05Streamlines the process for the CEO to comply with SEC reporting obligations, ensuring timely and accurate filings.

Related Party Transactions

  • Indirect beneficial ownership of 274,275 shares is held through the KANG & CECILLIA SUN FAMILY REVOCABLE TRUST, for which the reporting person and his spouse are co-trustees.

Stakeholder Impact

  • Shareholders may react to the significant insider sale, though the pre-planned nature under a 10b5-1 plan typically reduces negative market interpretation compared to unplanned sales.
  • The company's compliance and legal teams benefit from the Power of Attorney, which streamlines the executive's SEC filing process.

Key Dates

DateDescription
2022-09-14Date exercisable for certain stock options.
2025-08-18Rule 10b5-1 trading plan adopted by Kang Sun.
2025-11-05Effective date of Power of Attorney granted by Kang Sun.
2025-11-17Transaction date for stock option exercises and common stock sales.
2025-11-19Date Form 4 was signed by attorney-in-fact.
2026-12-14Expiration date for certain stock options.
2027-03-15Expiration date for certain stock options.

Recommendation

hold

The filing reports a significant insider sale by the CEO, which can sometimes signal a lack of confidence. However, the transaction was executed under a pre-arranged Rule 10b5-1 trading plan, adopted months prior, which suggests it was not based on immediate, non-public information. The CEO still retains a substantial beneficial ownership, including restricted stock units. Without additional context on the company's performance or strategic direction, this filing alone does not warrant a change from a 'hold' position, as it represents a planned monetization event rather than an urgent divestment.

Keywords

Amprius Technologies, AMPX, Kang Sun, Insider Trading, Form 4, Stock Options, Share Sale, CEO, 10b5-1 Plan, Battery Technology

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.